Balloon Sinus Dilation In Office or OR
ORIOS
ESS Performed in Operating Room Versus Clinician's Office
1 other identifier
interventional
72
1 country
1
Brief Summary
Endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed with or without balloon sinuplasty devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 14, 2009
CompletedFirst Posted
Study publicly available on registry
July 15, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedResults Posted
Study results publicly available
October 3, 2014
CompletedJuly 12, 2024
July 1, 2024
1.2 years
July 14, 2009
May 6, 2014
July 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Intra-patient Change in SNOT-20 Score at 24 Weeks Post-procedure Compared to Baseline
The 20 question Sino-Nasal Outcome Test (SNOT-20) will be used to evaluate sinus symptoms and sinus-symptom related quality of life (QOL) at baseline, 1 week, 4 weeks, 24 weeks and 52 weeks post-procedure. The change in SNOT-20 score at each post-procedure time point will be evaluated compared to baseline SNOT-20 score. Each of the 20 questions in the SNOT-20 survey is scored on a scale of 0 to 5, where '0' represents 'no problem' and '5' represents 'problem as bad as it can be'. The 20 questions are expressed as a mean of the scores. Therefore, the minimum mean score is zero and the maximum mean score is 5.
24 weeks
Secondary Outcomes (9)
Mean Intra-patient Change in Lund-MacKay CT Score [24 Weeks]
24 weeks
Proportion of Participants Rating Procedure as Tolerable (IO Only)
Day 0
Proportion of Participants Reporting No Pain or Pain of Low Intensity (IO Only)
Day 0
Mean Number of Debridements Per Participant (IO Only)
52 weeks
Proportion of Participants With Revisions (IO Only)
52 weeks
- +4 more secondary outcomes
Study Arms (2)
FESS in OR with or without balloons
ACTIVE COMPARATORFunctional Endoscopy Sinus Surgery
Balloon sinuplasty in physician office
ACTIVE COMPARATORBalloon Sinuplasty in physician office using Acclarent devices
Interventions
Intervention with metal instruments with or without balloon treatment
Eligibility Criteria
You may qualify if:
- Age 18 years and greater
- Both male and female patients eligible
- Diagnosis of chronic sinusitis that is not responsive to medical management (\> 12 weeks of symptoms and failed at least 3 to 6 weeks of appropriate antibiotic therapy as evidenced by presence of disease on CT scan)
- Planned endoscopic sinus surgery (recommended by investigator, consented to by patient)
You may not qualify if:
- Cystic fibrosis
- Samter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis)
- Sinonasal tumors or obstructive lesions
- History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium
- Ciliary dysfunction
- Pregnant females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Integra LifeSciences Corporationlead
- Acclarentcollaborator
Study Sites (1)
Rockside Road Surgery Center
Independence, Ohio, 44131, United States
Results Point of Contact
- Title
- Clinical Director
- Organization
- Acclarent, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Howard Levine, MD
Rockside Road Surgery Center Independence, OH
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2009
First Posted
July 15, 2009
Study Start
April 1, 2008
Primary Completion
June 1, 2009
Study Completion
July 1, 2010
Last Updated
July 12, 2024
Results First Posted
October 3, 2014
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share